icon-    folder.gif   Conference Reports for NATAP  
 
  22nd Conference on Retroviruses and
Opportunistic Infections
Seattle Washington Feb 23 - 26, 2015
Back grey_arrow_rt.gif
 
 
 
Cabotegravir and Rilpivirine As 2-Drug Oral Maintenance Therapy: LATTE W96 Results
 
 
  Reported by Jules Levin
 
CROI 2015 Feb 23-26, Seattle, WA
 
David Margolis1, Sandy Griffith1, Marty St. Clair1, William Spreen1, Cynthia Brinson2, Graham Smith3, Jerome de Vente4, Debbie Hagins5, Kimberly Smith6, Peter Williams7
1 GlaxoSmithKline, Durham, North Carolina, United States;2 Central Texas Clinical Research, Austin, Texas, United States;3 Maple Leaf Medical Clinic, Toronto, Ontario, Canada;4 Living Hope Foundation, Long Beach, California, United States;5 Chatham County Health Department, Savannah, Georgia, United States;6 ViiV Healthcare, Durham, North Carolina, United States;7 Janssen Pharmaceuticals, Inc, Beerse, Belgium

CROI1.gif

CROI2.gif

CROI3.gif

CROI4.gif

CROI5.gif

CROI6.gif